Mark Stanton

Mark Stanton has a strong background in market access and reimbursement, with experience in various pharmaceutical companies. Mark is currently serving as the Vice President of Market Access & Reimbursement at MacroGenics, Inc. Prior to that, they held the same position at Dova Pharmaceuticals and AMAG Pharmaceuticals. Mark also worked as the Head of Diabetes Market Access at AstraZeneca. Before that, they had a long tenure at MedImmune - Astra Zeneca's Biologics Division, where they held multiple roles including Vice President of Market Access and Reimbursement Division and Vice President of Managed Markets. Mark also has experience working at Endo Pharmaceuticals, Serono, Inc., Rhone-Poulenc Group Connaught Vaccines Division, BOEHRINGER MANNHEIM CORP, and STERLING DRUG CORP in various management and sales positions.

Mark Stanton attended Castleton State College from 1980 to 1984, where they earned a Bachelor's degree in Business Administration with a focus on Marketing/Marketing Management, General. In addition, they participated in leadership development programs at the Center for Creative Leadership's Looking Glass Leadership Development. Mark also completed the Program on Leadership for Senior Executives at Harvard University and took courses in Managed Care Strategies at the Kellogg Graduate School of Management. Furthermore, they attended the Leading Enterprise Transformation Program at the MIT Sloan School of Management and the Program for High Potential Leaders at The Wharton School.